0001179110-17-010591.txt : 20170721 0001179110-17-010591.hdr.sgml : 20170721 20170721161940 ACCESSION NUMBER: 0001179110-17-010591 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170719 FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reumuth Mary CENTRAL INDEX KEY: 0001710969 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 17976764 MAIL ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 edgar.xml FORM 4 - X0306 4 2017-07-19 0 0001479419 Kala Pharmaceuticals, Inc. KALA 0001710969 Reumuth Mary C/O KALA PHARMACEUTICALS, INC. 100 BEAVER STREET, SUITE 201 WALTHAM MA 02453 0 1 1 0 Chief Financial Officer Stock Option (right to buy) 15 2017-07-19 4 A 0 28973 0 A 2027-07-18 Common Stock 28973 28973 D This option was granted, effective on July 19, 2017 and vests over four years, with 2.0833% of the shares underlying the option vesting on August 31, 2017 and an additional 2.0833% of the shares vesting at the end of each successive one-month period thereafter. /s/ Mary Reumuth 2017-07-21